These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3523880)

  • 1. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
    Leivestad T; Albrechtsen D; Flatmark A; Thorsby E
    Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
    Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
    Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor transplants.
    Cecka JM
    Clin Transpl; 1995; ():363-77. PubMed ID: 8794280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatched living, related donor renal transplantation: a prospective, randomized study.
    Sommer BG; Ferguson RM
    Surgery; 1985 Aug; 98(2):267-74. PubMed ID: 3895539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
    Câmara NO; Dias MF; Pacheco-Silva A
    Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing long-term outcome of living-donor kidney transplantation in the cyclosporine era.
    Yoon YS; Bang BK; Jin DC; Ahn SJ; Yoon JY; Park YH; Koh YB
    Clin Transpl; 1992; ():257-66. PubMed ID: 1306704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppression and blood transfusions in patients with a kidney transplant].
    Vázquez Salas L; Arellano J; MacGregor Gooch J; Novelo B; Lizola Margolis I; Galván Plata ME
    Gac Med Mex; 1992; 128(3):253-7. PubMed ID: 1302725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry.
    Sonoda T; Ishibashi M
    Clin Transpl; 1987; ():257-60. PubMed ID: 2978999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific transfusion.
    Iwaki Y; Terasaki PI
    Clin Transpl; 1986; ():267-75. PubMed ID: 3154415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation from HLA-haploidentical living-related donors: the effects of donor-specific blood transfusions and different immunosuppressive regimens.
    Sakagami K; Saito S; Shiozaki S; Fujiwara T; Haisa M; Niguma T; Kusaka S; Uda M; Matsuno T; Takasu S
    Acta Med Okayama; 1992 Feb; 46(1):1-5. PubMed ID: 1561899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience of blood transfusion in renal transplantation.
    Frisk B; Berglin E; Blohmé I; Persson H; Sandberg L; Wedel N; Brynger H
    Scand J Urol Nephrol Suppl; 1984; 88():1-69. PubMed ID: 6399773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific blood transfusions versus cyclosporine--the DST story.
    Salvatierra O; Melzer J; Vincenti F; Amend WJ; Tomlanovich S; Potter D; Husing R; Garovoy M; Feduska NJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):160-6. PubMed ID: 3547813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.